Reversible Cerebral Vasoconstriction Syndrome - What is it, what causes it, how do we treat it?

Newark, DE US
December 30, 2019

This activity will address the need and problem of lack of insight into how to recognize and treat reversible cerebral vasoconstriction syndrome by providing comprehensive education focusing on clinical features, diagnostic criteria, common precipitating factors, neuroimaging and pathophysiology related to reversible cerebral vasoconstriction syndrome. The continuing education activity will also review treatment management, as well as, primary literature to support the treatment recommendations.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives
  1. Describe epidemiology, clinical features, and diagnostic criteria associated with reversible cerebral vasoconstrictive syndrome
  2. Review participants, neuroimaging and pathophysiology related to reversible cerebral vasoconstrictive syndrome
  3. Describe treatment and prevention measures associated with reversible cerebral vasoconstrictive syndrome
  4. Review primary literature related to the management of reversible cerebral vasoconstrictive syndrome
 
Pharmacy technician learning objectives
  1. Recognize medications used for the treatment of reversible cerebral vasoconstrictive syndrome
  2. Describe the role of medications used for the treatment of reversible cerebral vasoconstrictive syndrome
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance
Course opens: 
12/30/2019
Course expires: 
01/17/2020
Event starts: 
12/30/2019 - 12:00pm
Event ends: 
12/30/2019 - 1:00pm
Cost:
$0.00
ChristianaCare
4755 Ogletown Stanton Rd.
Newark, DE 19713
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
 
Planning committee members
Tep Kang, PharmD, BCPS
Clinical Pharmacy Specialist, Surgical Critical Care
ChristianaCare
 
Mohamed Elmarakbi, PharmD
PGY-1 Pharmacy Practice Resident
ChristianaCare
 
Course reviewer
Katrina Harper, PharmD, MBA, BCPS, DPLE
Clinical Pharmacy Director
Vizient
 
Presenter
Mohamed Elmarakbi, PharmD
PGY-1 Pharmacy Practice Resident
ChristianaCare
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and ChristianaCare.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-19-229-L01-P
Universal Activity Number: JA0006103-9999-19-229-L01-T
 
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance

Price

Cost:
$0.00
Please login or register to take this course.